Documentation & Clinical Communication Flashcards
7 cards from real MTM practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Documentation & Clinical Communication flashcards as text
Which of the following is a required element of the written CMR summary that must be provided to the patient under CMS MTM program guidelines?
Answer: A cover letter, Personal Medication Record, and Medication Action Plan
CMS requires CMR written summaries to include a cover letter explaining the MTM program, a complete PMR, and a patient-centered MAP.
When communicating an urgent drug-related safety concern (e.g., critical drug interaction) to a prescriber, the MTM pharmacist should FIRST:
Answer: Contact the prescriber by phone immediately and document the communication
Urgent safety concerns require immediate verbal contact with the prescriber followed by written documentation to ensure prompt action and accountability.
Proper documentation of a patient's health literacy level during MTM is important primarily because it:
Answer: Guides how the pharmacist tailors communication and written materials for the patient
Documenting health literacy allows future care providers to use appropriately tailored communication strategies, improving comprehension and adherence.
A pharmacist documents a 'Drug Without Indication' as a drug-related problem in an MTM note. Which additional documentation is MOST important to include?
Answer: The specific medication identified, the basis for the finding, and the recommended action
DRP documentation must specify the offending agent, clinical evidence supporting the finding, and the pharmacist's recommended course of action.
In MTM documentation, 'therapeutic duplication' should be recorded as a drug-related problem when:
Answer: Two or more medications provide the same pharmacological effect without added benefit
Therapeutic duplication is defined as two or more medications providing the same therapeutic effect without demonstrated additive benefit, increasing adverse event risk.
Which professional standard requires MTM pharmacists to document that they obtained informed consent before conducting a CMR?
Answer: CMS MTM program eligibility rules requiring beneficiary agreement to participate
CMS MTM programs require that enrolled beneficiaries agree to participate; this beneficiary opt-in consent should be documented before conducting the CMR.
After identifying a subtherapeutic dose during an MTM visit, a pharmacist documents a recommendation to increase the dose. The prescriber disagrees. The pharmacist should document:
Answer: The recommendation made, the prescriber's response, and any agreed-upon monitoring plan
Full documentation of the recommendation, prescriber's response, and any monitoring plan preserves the clinical record and supports ongoing collaborative care.